Clinical Trial Update: ROADSTER 3 Extended Follow-up Sub-Study

View source ↗

Summary

Silk Road Medical's ROADSTER 3 extended follow-up sub-study investigating carotid artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Diseases

Snippet

Sponsor: Silk Road Medical | Conditions: Carotid Artery Diseases | Status: TERMINATED